What does Dr. Nele Van Langenhove do?

Dr. Nele Van Langenhove is a specialist medical practice in Dendermonde. Private Limited, started on 28 January 2019, 1 establishment.

What is the address of Dr. Nele Van Langenhove?

The registered office of Dr. Nele Van Langenhove is located at Moesweide(STG) 11, 9200 Dendermonde.

Is Dr. Nele Van Langenhove still active?

Yes. According to the CBE (29 September 2026) Dr. Nele Van Langenhove is active, legal situation “Normale toestand”, started on 28 January 2019.

Is Dr. Nele Van Langenhove registered on Peppol?

Yes, Dr. Nele Van Langenhove is registered on the Peppol network with ID 0208:0719495619.

What is the enterprise number of Dr. Nele Van Langenhove?

The enterprise number of Dr. Nele Van Langenhove is BE0719495619.

When was Dr. Nele Van Langenhove founded?

Dr. Nele Van Langenhove was founded on 28 January 2019.

Who are the directors of Dr. Nele Van Langenhove?

According to the 2025 annual accounts, the directors of Dr. Nele Van Langenhove are: Nele Van Langenhove.

Is Dr. Nele Van Langenhove a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 January 2019; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Nele Van Langenhove make in 2025?

Dr. Nele Van Langenhove posted a profit after taxes of € 132,118 in financial year 2025.

What is the revenue of Dr. Nele Van Langenhove?

As a small company, Dr. Nele Van Langenhove is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 244,898.

Dr. Nele Van Langenhove (Private Limited) - Dendermonde

Dossier Dr. Nele Van Langenhove, printed on 29 September 2026 from databakkes.be/en/0719495619/dr-nele-van-langenhove. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Nele Van Langenhove from Dendermonde, company number BE0719495619, closed financial year 2025 with a result of € 132,118 after tax. For that financial year Dr. Nele Van Langenhove recorded a gross margin of € 244,898 and equity of € 18,600. Compared with financial year 2024, the result moved from € 121,472 to € 132,118. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on December 15, 2025.

What it is worth Healthy

€ 18,600

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 132,118

▲ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 161,098

▼ 25% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 132,118 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 18,877

▼ 38% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 227,939

▼ 29% vs 2024

€ 87,558 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 4,075

▲ € 3,873 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 7,532

▲ 75% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 201,732 Gross margin 2022: € 201,732 First fiscal year in the series	€ 205,134 Gross margin 2023: € 205,134 ▲ 2% vs 2022 (€ 201,732) Favourable step	€ 230,610 Gross margin 2024: € 230,610 ▲ 12% vs 2023 (€ 205,134) Favourable step	€ 244,898 Gross margin 2025: € 244,898 ▲ 6% vs 2024 (€ 230,610) Favourable step	▲ 6%
Profit after taxes	€ 103,810 Profit after taxes 2022: € 103,810 First fiscal year in the series	€ 101,049 Profit after taxes 2023: € 101,049 ▼ 3% vs 2022 (€ 103,810) Unfavourable step	€ 121,472 Profit after taxes 2024: € 121,472 ▲ 20% vs 2023 (€ 101,049) Favourable step	€ 132,118 Profit after taxes 2025: € 132,118 ▲ 9% vs 2024 (€ 121,472) Favourable step	▲ 9%
Equity	€ 315,839 Equity 2022: € 315,839 First fiscal year in the series	€ 169,830 Equity 2023: € 169,830 ▼ 46% vs 2022 (€ 315,839) Unfavourable step	€ 18,600 Equity 2024: € 18,600 ▼ 89% vs 2023 (€ 169,830) Unfavourable step	€ 18,600 Equity 2025: € 18,600 Unchanged (€ 18,600) Unchanged
Total debts	€ 501,947 Total debts 2022: € 501,947 First fiscal year in the series	€ 416,466 Total debts 2023: € 416,466 ▼ 17% vs 2022 (€ 501,947) Favourable step	€ 600,975 Total debts 2024: € 600,975 ▲ 44% vs 2023 (€ 416,466) Unfavourable step	€ 375,603 Total debts 2025: € 375,603 ▼ 38% vs 2024 (€ 600,975) Favourable step	▼ 38%
Cash	€ 357,443 Cash 2022: € 357,443 First fiscal year in the series	€ 207,772 Cash 2023: € 207,772 ▼ 42% vs 2022 (€ 357,443) Unfavourable step	€ 214,208 Cash 2024: € 214,208 ▲ 3% vs 2023 (€ 207,772) Favourable step	€ 161,098 Cash 2025: € 161,098 ▼ 25% vs 2024 (€ 214,208) Unfavourable step	▼ 25%
Retained profit	€ 297,239 Retained profit 2022: € 297,239 First fiscal year in the series	€ 151,230 Retained profit 2023: € 151,230 ▼ 49% vs 2022 (€ 297,239) Unfavourable step	€ 0 Retained profit 2024: € 0 ▼ 100% vs 2023 (€ 151,230) Unfavourable step	€ 0 Retained profit 2025: € 0 Unchanged (€ 0) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 247,059 Dividend 2023: € 247,059 Unchanged (€ 0) Unchanged	€ 272,702 Dividend 2024: € 272,702 ▲ 10% vs 2023 (€ 247,059) Unchanged	€ 132,118 Dividend 2025: € 132,118 ▼ 52% vs 2024 (€ 272,702) Unchanged	▼ 52%
Bank debt	€ 497,053 Bank debt 2022: € 497,053 First fiscal year in the series	€ 407,953 Bank debt 2023: € 407,953 ▼ 18% vs 2022 (€ 497,053) Favourable step	€ 319,083 Bank debt 2024: € 319,083 ▼ 22% vs 2023 (€ 407,953) Favourable step	€ 227,939 Bank debt 2025: € 227,939 ▼ 29% vs 2024 (€ 319,083) Favourable step	▼ 29%
Balance sheet total	€ 817,786 Balance sheet total 2022: € 817,786 First fiscal year in the series	€ 586,296 Balance sheet total 2023: € 586,296 ▼ 28% vs 2022 (€ 817,786) Unchanged	€ 619,575 Balance sheet total 2024: € 619,575 ▲ 6% vs 2023 (€ 586,296) Unchanged	€ 394,203 Balance sheet total 2025: € 394,203 ▼ 36% vs 2024 (€ 619,575) Unchanged	▼ 36%

Key figures of Dr. Nele Van Langenhove, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Dr. Nele Van Langenhove?

What happened at Dr. Nele Van Langenhove in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 15, 2025 New annual accounts for financial year 2025: profit of € 132,118 (▲ 9% vs 2024). Source: NBB ↗
Jan 28, 2019 New establishment in Dendermonde. KBO
Jan 28, 2019 Start of the company according to the CBE. KBO
2019 Nele Van Langenhove became a director. NBB

In short

From € 103,810 profit in 2022 to € 132,118 profit in 2025.

Paid € 128,983 in corporate taxes since 2022.

Best year ever: 2025, with € 132,118 profit.

Paid out € 651,878 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Nele Van Langenhove? We notify you, reason included.

Follow Dr. Nele Van Langenhove

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Nele Van Langenhove

Dr. Nele Van Langenhove

Behind Dr. Nele Van Langenhove is Nele Van Langenhove.

See the full network in the app

Directors

According to the 2025 annual accounts

Nele Van Langenhove

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Moesweide(STG) 11

9200 Dendermonde

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0719.495.619
VAT number: BE 0719.495.619
Registered office: Moesweide(STG) 11, 9200 Dendermonde
Names & denominations: Dr. Nele Van Langenhove
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 January 2019
Peppol: Active · Active since 27 Mar 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗